Uveitis Treatment Market Size, Share, Growth Report 2030

Uveitis Treatment Market

Uveitis Treatment Market: by Treatment type (corticosteroids, immunosuppressant, monoclonal antibodies, cycloplegic agents, antibiotics, antivirals, antifungal, and analgesics), Disease type (anterior uveitis, posterior uveitis, intermediate uveitis and panuveitis), Distribution Channel (hospitals, ophthalmology clinics, ambulatory surgical centers, and others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Published Date: 23-Oct-2019 Category: Healthcare Report Format : PDF Pages: 130 Report Code: ZMR-4904 Status : Published

The global uveitis treatment market size reached USD 474.34 Million in 2018 and is expected to generate revenue of around USD 727.75 Million by end of 2025, growing at a CAGR of around 6.35% between 2019 and 2025.

Uveitis Treatment Market: Industry Perspective

The report covers forecast and analysis for the Uveitis Treatment market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Uveitis Treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Uveitis Treatment market on a global level. In order to give the users of this report a comprehensive view of the Uveitis Treatment market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein treatment type, disease type, distribution channel, and regional segments are benchmarked based on their market size, growth rate, and general attractiveness.

Uveitis is the inflammation of the eye's middle layer called the uvea. It may emerge from causes that are both infectious and non-infectious. The uvea supplies the retina with blood. The retina is the light-sensitive part of the eye that focuses and sends the images to the brain. Because of its blood supply from the uvea, it is usually red. Uveitis is not usually severe. If not treated early, more severe cases may cause vision loss. In one or both eyes, the following symptoms may occur severe redness in the eye, pain, dark floating spots in your vision, called floaters, light sensitivity, and blurred vision. The cause of uveitis is often uncertain and often happens in people who are otherwise well. Sometimes it can be linked with another illness such as an autoimmune disorder or a virus or bacterial infection.

Global Uveitis Treatment Market Request Free Sample

The study provides a decisive view of the Uveitis Treatment market by segmenting the market based on treatment type, disease type, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on product, the market is segmented into corticosteroids, immunosuppressants, monoclonal antibodies, cycloplegic agents, antibiotics, antivirals, antifungals, and analgesics. In 2018, corticosteroids dominated the market for anterior uveitis treatment as they are anterior uveitis first-line therapies. They are used as both eye drops and systematic therapy. Corticosteroids are also used in the treatment of continued release, i.e., in implants of the eye. Based on disease type, the market is segmented into anterior uveitis, posterior uveitis, intermediate uveitis, and panuveitis. Anterior uveitis led the market space in 2018 due to the high prevalence of adult and youth conditions. Increasing work in this field also illustrates the rising age of this type of disease. There is a high risk of loss of vision and cataracts, glaucoma, or retinal edema for people with untreated anterior uveitis. Based on the distribution channel, the market is segmented into hospitals, ophthalmology clinics, ambulatory surgical centers, and others. Due to the availability of a wide range of options for managing eye inflammation in hospitals, hospital pharmacies led the market in 2018 based on the distribution channel. In addition, hospitals provide a significant number of patients with treatment and care, making hospital pharmacies a leading category. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa with its further bifurcation into major countries such as the US, Canada, Germany, UK, France, China, Japan, India, GCC countries, Brazil. Due to the rising prevalence of non-infectious uveitis in the United States, North America led the market in 2018. Additionally, advanced health care facilities and reimbursement policies are attributed to stimulating regional development. Large numbers of drugs are available commercially in the U.S., further boosting the country's demand.

New developments in drug formulations and treatment modalities are continuing, for instance, a major breakthrough was Humira's approval for uveitis care. As a consequence, some of the driving factors are projected to be factors such as the rising geriatric population, increasing disease incidence, and new product innovations Redness of the eyes, blurring of the vision, the small size of the pupil, and sensitivity to light may be signs of anterior uveitis that may result in permanent blindness if not treated. The increasing occurrence of optical infections coupled with increased knowledge of different treatments is likely to help the growth of the market over the forecast period. Some other drivers of the industry are high spending on insurance, increased disposable income, and favorable government regulations.

Key players within the global Uveitis Treatment market include Allergan, Inc.; Bausch & Lomb Incorporated; Santen Pharmaceutical Co., Ltd; AbbVie Inc.; Novartis AG; Eyegate Pharmaceuticals, Inc.; Regeneron Pharmaceuticals, Eyepoint Pharmaceuticals Inc.; and Alimera Sciences, Inc. amongst others.

The report segments the global Uveitis Treatment market as follows:

Global Uveitis Treatment Market: Treatment type Segment Analysis

  • Corticosteroids
  • Immunosuppressant
  • Monoclonal Antibodies
  • Cycloplegic Agents
  • Antibiotics
  • Antivirals
  • Antifungal
  • Analgesics

Global Uveitis Treatment Market: Disease type Segment Analysis

  • Anterior Uveitis
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis

Global Uveitis Treatment Market: Distribution Channel Segment Analysis

  • Hospitals
  • Ophthalmology Clinics
  • Ambulatory Surgical Centers
  • Others

Global Uveitis Treatment Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Table Of Content


Choose License Type

  • zion payment modes


Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed